Addus HomeCare Q2 2026: Revenue Climbs 8% to $377M, Adjusted EPS of $1.73 Beats by 16%
ADUS sits 28% above its 52-week low of $87.95.
Summary
Addus HomeCare reported Q2 2026 revenue of $377.4 million, up 8% year-over-year, with adjusted EPS of $1.73 beating the prior year by 16.1%. Strong organic growth in personal care and hospice, coupled with rate increases and a recent acquisition, drove the outperformance.
Key Events · Earnings and Guidance · ADUS
-
Revenue and Earnings Beat
Q2 2026 net service revenues rose 8.0% to $377.4 million, with net income of $27.6 million ($1.49 diluted EPS). Adjusted diluted EPS of $1.73 exceeded the prior year's $1.49 by 16.1%.
-
Segment Growth Drivers
Personal care organic revenue grew 6.8%, aided by rate increases in Texas (9.9%) and Illinois (3.9%). Hospice organic revenue jumped 11.1% on higher average daily census and revenue per patient day. Home health organic revenue declined 2.8%.
-
Cash Flow and Balance Sheet Strength
Operating cash flow was $40.0 million for Q2 2026, nearly double the prior year. Cash stood at $99.6 million with bank debt of $64.3 million and $577.8 million available under the revolving credit facility as of June 30, 2026.
-
Acquisition and M&A Outlook
The acquisition of HomeCourt Home Care on May 1, 2026, contributed two months of operations. Management highlighted a strong balance sheet and low leverage to pursue further targeted acquisitions to enhance market density.
Analysis · ADUS · Industrial Applications And Services
A strong second quarter for Addus HomeCare saw revenue rise 8% to $377.4 million, while adjusted earnings per share surged 16.1% to $1.73. The personal care segment delivered 6.8% organic revenue growth, lifted by rate increases in Texas and Illinois, and hospice organic revenue jumped 11.1%. Operating cash flow nearly doubled year-over-year to $40 million, and the balance sheet remains robust with $99.6 million in cash and low leverage. These results highlight the company's ability to drive profitable growth in the home care market, though the home health segment continues to lag with a 2.8% organic revenue decline. The acquisition of HomeCourt Home Care contributed two months of operations, and management signaled continued appetite for M&A to build density. With a conference call tomorrow, investors will look for commentary on the sustainability of these trends and the pipeline for further acquisitions.
At the time of this filing, ADUS was trading at $112.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $87.95 to $124.44. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.